AI assistant
IPG PHOTONICS CORP — Regulatory Filings 2021
May 4, 2021
31300_rns_2021-05-04_287c34ad-8af4-4a9d-bc93-82176b2e48d0.zip
Regulatory Filings
Open in viewerOpens in your device viewer
DEFA14A 1 defa14a.htm DEFA14A html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document created using Wdesk Copyright 2021 Workiva Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant ý
Filed by a Party other than the Registrant ¨
Check the appropriate box:
| o | Preliminary Proxy Statement |
|---|---|
| o | Confidential, for Use of the Commission Only (as permitted by Rule 14a- 6(e)(2)) |
| o | Definitive Proxy Statement |
| x | Definitive Additional Materials |
| o | Soliciting Material Pursuant to §240.14a-12 |
IPG PHOTONICS CORPORATION
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant
Payment of Filing Fee (Check the appropriate box):
| ý | No fee required. | |
|---|---|---|
| o | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |
| (1) | Title of each class of securities to which transaction applies: | |
| (2) | Aggregate number of securities to which transaction applies: | |
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |
| (4) | Proposed maximum aggregate value of transaction: | |
| (5) | Total fee paid: | |
| o | Fee paid previously with preliminary materials. | |
| o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing. | |
| (1) | Amount Previously Paid: | |
| (2) | Form, Schedule or Registration Statement No.: | |
| (3) | Filing Party: | |
| (4) | Date Filed: |
EXPLANATORY NOTE
This Amendment No. 2 to Schedule 14A is being filed by IPG Photonics Corporation to supplement its definitive proxy statement for the Annual Meeting of Stockholders to be held on May 25, 2021, which was filed with the U.S. Securities and Exchange Commission on April 9, 2021 and amended on April 15, 2021, in order to update the biographies and other related disclosures on two executive officers being nominated for reelection to the Board of Directors of the Company. Except as specifically provided in this supplement, this supplement does not otherwise modify or update any other disclosures presented in the proxy statement. In addition, this supplement does not reflect any other events occurring after the date of the proxy statement or modify or update disclosures that may have been affected by subsequent events.
SUPPLEMENTAL INFORMATION REGARDING
THE ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON MAY 25, 2021
THIS NOTICE SHOULD BE READ TOGETHER WITH THE PROXY STATEMENT
The following information amends the Definitive Proxy Statement on Schedule 14A filed by IPG Photonics Corporation (the “Company”) with the U.S. Securities and Exchange Commission on April 9, 2021 (the “Original Filing”), as amended by Amendment No. 1 to the Original Filing, filed on April 15, 2021 (collectively, the “Amended Filing”), in connection with the Company’s Annual Meeting of Stockholders to be held on May 25, 2021 (the “Annual Meeting”), and should be read together with the Amended Filing. Other than as set forth below, no changes have been made to the Amended Filing.
On May 4, 2021, the Company announced that Valentin P. Gapontsev, Ph.D., transitioned to the role of Executive Chair of the Company’s Board of Directors (“Board”) and will continue to serve as a director of the Company. Eugene A. Scherbakov, Ph.D., currently Chief Operating Officer, Managing Director of IPG Laser GmbH, Senior Vice President of Europe and Director, succeeds Dr. Gapontsev as the Company’s Chief Executive Officer effective immediately. Dr. Scherbakov has served as Managing Director of IPG Laser GmbH, IPG’s German subsidiary, since August 2000, Senior Vice President-Europe since February 2013 and Chief Operating Officer since February 2017. Dr. Scherbakov has also been a member of the Board since 2000 and will continue as a director. Further information associated with the transition described in this supplement is available in the Company’s Current Report on Form 8-K filed with the SEC on May 4, 2021, which is accessible on the Company’s website.
Supplemental Disclosure to Proxy Statement
The section titled “Director Nominees” on page 13 of the Amended Filing contains information regarding Dr. Gapontsev’s and Dr. Scherbakov’s biographies and related information. Such information is revised as follows to reflect Dr. Gapontsev’s transition from Chief Executive Officer to Executive Chair and Dr. Scherbakov’s transition from Chief Operating Officer, Managing Director of IPG Laser GmbH, Senior Vice President of Europe and Director to Chief Executive Officer, both effective May 4, 2021:
Valentin P. Gapontsev, Ph.D.
Executive Chair of the Board
| ● | ||||||
|---|---|---|---|---|---|---|
| AGE: 82 DIRECTOR SINCE: 1998 COMMITTEES: None | ||||||
| ● | ● | ● | ● | ● | ● | ● |
| Lasers and Technology | Financial Literacy | Global Business | Manufacturing and Operating | Business Development and M&A | Risk Management | Executive Leadership |
Eugene A. Scherbakov, Ph.D.
Chief Executive Officer and Director
| ● | ||||||
|---|---|---|---|---|---|---|
| AGE: 73 DIRECTOR SINCE: 2000 COMMITTEES: None | ||||||
| ● | ● | ● | ● | ● | ● | ● |
| Lasers and Technology | Financial Literacy | Global Business | Manufacturing and Operating | Business Development and M&A | Risk Management | Executive Leadership |